PRRT2 and breast cancer: Moreover, MKP1 has also been positively related to tumor progression in lung cancer (by downregulating JNK and p38 kinases)21, 34, in breast cancer by inducing epithelial mesenchymal transition and PKC pathway, and in hepatocellular carcinoma by inhibiting ERK activity35.